Zobrazeno 1 - 10
of 102
pro vyhledávání: '"F. Tricta"'
Publikováno v:
HemaSphere, Vol 6, Pp 1392-1393 (2022)
Externí odkaz:
https://doaj.org/article/2c3d5e6cf6dd4cdd9b41e95f7acc69ee
Publikováno v:
HemaSphere, Vol 6, Pp 1439-1440 (2022)
Externí odkaz:
https://doaj.org/article/6b710d9f1b2245129bd6676334bd11d5
Publikováno v:
HemaSphere, Vol 6, Pp 2101-2102 (2022)
Externí odkaz:
https://doaj.org/article/3f5eba2ce8914aaea314180fb84cb61b
Autor:
MPA Verissimo, MS Elalfy, M Hamdy, A El-Beshlawy, F Ebeid, J Kanter, S Williams, D Lee, F Tricta, JL Kwiatkowski
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S23-S24 (2021)
Objectives: Assess the safety and efficacy of deferiprone (DFP) in chronically transfused, iron-overloaded patients with sickle cell disease (SCD) or other anemias. Methods: FIRST was a multicenter, 1-year, noninferiority trial of DFP vs deferoxamine
Externí odkaz:
https://doaj.org/article/a031bbe1c98a4b1fa51a8b9c7bd6aa6b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Hamdy, A El-Beshlawy, FS Ebeid, JL Kwiatkowski, J Kanter, B Inusa, S Williams, M Verissimo, D Lee, NT Temin, C Fradette, F Tricta, MS Elalfy
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S338-S339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d252cb02199c2f4a135ffd0f026803d
https://doi.org/10.1016/j.htct.2022.09.573
https://doi.org/10.1016/j.htct.2022.09.573
Autor:
B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Publikováno v:
HemaSphere. 6:10-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cee7b1bde1ba3418ceefe4cbb3ae94fc
https://doi.org/10.1097/01.hs9.0000821448.70992.5a
https://doi.org/10.1097/01.hs9.0000821448.70992.5a
Autor:
M Elalfy, A El-Beshlawy, A Adly, F Ebeid, C Fradette, D Lee, N Temin, F Tricta, A Rozova, M Hamdy
Publikováno v:
HemaSphere. 6:12-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52ae111d425207f9a33a9e1ba5f71abe
https://doi.org/10.1097/01.hs9.0000821460.57070.77
https://doi.org/10.1097/01.hs9.0000821460.57070.77
Autor:
Amal El-Beshlawy, Janet L. Kwiatkowski, Mpa Verissimo, Elalfy, Julie Kanter, Mona Hamdy, Suzan Williams, F Tricta, D Lee, Fatma S E Ebeid
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S23-S24 (2021)
Objectives: Assess the safety and efficacy of deferiprone (DFP) in chronically transfused, iron-overloaded patients with sickle cell disease (SCD) or other anemias. Methods: FIRST was a multicenter, 1-year, noninferiority trial of DFP vs deferoxamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44bea2a7bc96ed43454a192b54566665
https://doi.org/10.1016/j.htct.2021.10.040
https://doi.org/10.1016/j.htct.2021.10.040
Autor:
B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Publikováno v:
HemaSphere. 6:8-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86d82d025e68877602c082c68babb7dc
https://doi.org/10.1097/01.hs9.0000821428.51427.ac
https://doi.org/10.1097/01.hs9.0000821428.51427.ac